Breast
Featured Articles
(The Motley Fool) Aug 22, 2017 - Eli Lilly, Incyte, and Johnson & Johnson could have the most exciting late-stage oncology candidates.
Read Article
(Broad Institute) Aug 21, 2017 - A mutation pattern or 'signature' linked to defects in 2 genes points to other ways an important DNA repair mechanism can be shut off in breast cancer.
Read Article
Latest Articles
August 22, 2017
August 22, 2017
August 21, 2017
August 21, 2017
August 21, 2017
August 21, 2017
August 18, 2017
August 18, 2017
View More
News Commentary
Editor Image
10 Dec, 2016 | by Dean Gesme, MD
It is encouraging to see three competing CDK 4/6 inhibitors soon to be...
View Comment
Editor Image
15 Feb, 2017 | by William Harwin MD
At Florida Cancer Specialists we have been using DigniCap for several months at...
View Comment
View More
OBR Green
There are no Breast OBR Green articles.
OBR Blog
By Jay Grisolano, PhD and Stephanie Ritz, PhD Approximately a quarter of breast cancer patients are classified as... Read more
June 05, 2017
By Liseth Parra, Ph.D., and Stephanie Hawthorne, Ph.D.   A very exciting therapeutic area that has been constantly... Read more
June 05, 2017